MMedication Read More FDA Actions to Support and Strengthen Domestic Drug ManufacturingJuly 11, 2026 The FDA is taking decisive steps to help strengthen U.S. pharmaceutical manufacturing, improve supply chain resilience, and ensure…
MMedication Read More Study Compares GLP-1 Drugs on Their Benefits, HarmsJuly 11, 2026 A network meta-analysis backed weight-loss benefits with several GLP-1 receptor agonists, with less certainty for newer-generation agents.Two GLP-1…
MMedication Read More Pharmacist issues warning for 10 medicines taken during hot weatherJuly 10, 2026 Hot temperatures will continue over the weekend 13:47, 10 Jul 2026Updated 14:54, 10 Jul 2026 People should be…
MMedication Read More Demystifying the molecular mechanisms of general anesthesiaJuly 10, 2026 Researchers at Weill Cornell Medicine and Birkbeck, University of London, have identified a site where a commonly used…
MMedication Read More SOP in pipeline for homeopaths to prescribe modern medicines: MMC | Mumbai NewsJuly 10, 2026 There were widespread protests by doctors last year over the decision to include homeopaths in modern medicine Mumbai:…
MMedication Read More Tens of thousands join stampede for first Wegovy weight-loss pill – The TimesJuly 10, 2026 Tens of thousands join stampede for first Wegovy weight-loss pill The TimesI tried the weight-loss pill — here’s what…
MMedication Read More China adds second GLP-1 diabetes drug to essential medicine listJuly 10, 2026 SHANGHAI — China will add a second GLP-1 drug, used to treat diabetes, to a list of essential…
MMedication Read More FDA recalls more than 2.5 million bottles of commonly prescribed steroid eye dropsJuly 10, 2026 The FDA has announced a class two recall of more than two and a half million bottles of…
MMedication Read More South Africa escalates Ozempic crackdown as doctors risk losing licences over copycat weight-loss drugsJuly 10, 2026 The coordinated action by the South African Health Products Regulatory Authority (SAHPRA), the South African Pharmacy Council…
MMedication Read More Mavenclad pulls double duty for MS, other autoimmune conditionsJuly 10, 2026 In addition to controlling multiple sclerosis (MS), the approved therapy Mavenclad (cladribine) may also help manage certain coexisting…
MMedication Read More Revere uses opioid settlement money to enlist businesses in the fight against overdosesJuly 10, 2026 On a recent morning, a co-owner of Revere cafe Chocolafee, Diana Cardona, switched up her 12-hour workday of…
MMedication Read More GLP-1 drug popularity is outpacing the science, Madison doctor says | HealthJuly 10, 2026 The Cap Times is an independent newsroom serving Madison and Wisconsin. Sign up for the Morning Update to…